Hillary L. Sturgis

526 total citations
6 papers, 382 citations indexed

About

Hillary L. Sturgis is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Hillary L. Sturgis has authored 6 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Hillary L. Sturgis's work include Protein Kinase Regulation and GTPase Signaling (4 papers), Melanoma and MAPK Pathways (4 papers) and HER2/EGFR in Cancer Research (1 paper). Hillary L. Sturgis is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), Melanoma and MAPK Pathways (4 papers) and HER2/EGFR in Cancer Research (1 paper). Hillary L. Sturgis collaborates with scholars based in United States. Hillary L. Sturgis's co-authors include W.C. Voegtli, Guy Vigers, Barbara J. Brandhuber, Wen‐I Wu, Steve Wenglowsky, Susan L. Gloor, David Moreno‐Mateos, Li Ren, Ellen R. Laird and Joachim Rudolph and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Hillary L. Sturgis

6 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hillary L. Sturgis United States	6	301	115	65	39	31	6	382
Lei Du‐Cuny United States	12	333 1.1×	85 0.7×	115 1.8×	27 0.7×	51 1.6×	14	467
Aras Emdadi United States	10	359 1.2×	139 1.2×	103 1.6×	51 1.3×	71 2.3×	10	479
A. Jestel Germany	6	213 0.7×	88 0.8×	44 0.7×	43 1.1×	51 1.6×	8	341
Scott Wolfrom United States	6	251 0.8×	128 1.1×	84 1.3×	27 0.7×	58 1.9×	7	446
María I. Albarrán Spain	11	199 0.7×	122 1.1×	35 0.5×	61 1.6×	40 1.3×	14	304
Catherine A. Luu United States	4	407 1.4×	148 1.3×	56 0.9×	17 0.4×	44 1.4×	5	471
Anthony S. Prokopowicz United States	9	174 0.6×	195 1.7×	40 0.6×	55 1.4×	57 1.8×	10	352
Tatiana McHardy United Kingdom	8	281 0.9×	148 1.3×	72 1.1×	34 0.9×	62 2.0×	11	389
Jiong Lan China	11	202 0.7×	134 1.2×	40 0.6×	44 1.1×	84 2.7×	35	339
Matthew Martinson United States	10	226 0.8×	162 1.4×	79 1.2×	65 1.7×	42 1.4×	12	344

Countries citing papers authored by Hillary L. Sturgis

Since Specialization

Citations

This map shows the geographic impact of Hillary L. Sturgis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hillary L. Sturgis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hillary L. Sturgis more than expected).

Fields of papers citing papers by Hillary L. Sturgis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hillary L. Sturgis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hillary L. Sturgis. The network helps show where Hillary L. Sturgis may publish in the future.

Co-authorship network of co-authors of Hillary L. Sturgis

This figure shows the co-authorship network connecting the top 25 collaborators of Hillary L. Sturgis. A scholar is included among the top collaborators of Hillary L. Sturgis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hillary L. Sturgis. Hillary L. Sturgis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wenglowsky, Steve, Li Ren, Jonas Grina, et al.. (2014). Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 24(8). 1923–1927. 16 indexed citations

2.

Hinklin, Ronald J., Thomas D. Aicher, Deborah Anderson, et al.. (2014). Discovery of 2-Pyridylureas as Glucokinase Activators. Journal of Medicinal Chemistry. 57(19). 8180–8186. 17 indexed citations

3.

Wenglowsky, Steve, David Moreno‐Mateos, Ellen R. Laird, et al.. (2012). Pyrazolopyridine inhibitors of B-RafV600E. Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(19). 6237–6241. 27 indexed citations

4.

Ren, Li, Kateri A. Ahrendt, Jonas Grina, et al.. (2012). The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 22(10). 3387–3391. 14 indexed citations

5.

Wenglowsky, Steve, Kateri A. Ahrendt, Bainian Feng, et al.. (2011). Pyrazolopyridine inhibitors of B-RafV600E. Part 2: Structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 21(18). 5533–5537. 50 indexed citations

6.

Wu, Wen‐I, et al.. (2010). Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition. PLoS ONE. 5(9). e12913–e12913. 258 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact